ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | -13.0% | 24 | 0.0% | 0.00% | – |
Q2 2023 | $23 | +21.1% | 24 | 0.0% | 0.00% | – |
Q1 2023 | $19 | -68.3% | 24 | 0.0% | 0.00% | – |
Q4 2022 | $60 | – | 24 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 24 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 1,226,191 | $3,077,739 | 0.20% |
Knott David M Jr | 140,000 | $351 | 0.13% |
Anson Funds Management LP | 129,795 | $325,785 | 0.05% |
Meridian Wealth Management, LLC | 71,750 | $180,093 | 0.02% |
Anson Funds Management LP | 38,100 | $95,631 | 0.02% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 19,000 | $48 | 0.01% |
Virtu Financial LLC | 10,557 | $26 | 0.00% |
TWO SIGMA SECURITIES, LLC | 19,747 | $49,565 | 0.00% |
UBS Group AG | 1,393 | $3,497 | 0.00% |
SVB WEALTH LLC | 11,500 | $28,865 | 0.00% |